| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis
|
Frere, Corinne
|
|
|
22 |
9 |
p. 2608-2628
|
artikel
|
| 2 |
Aging-related alterations in mechanistic target of rapamycin signaling promote platelet hyperreactivity and thrombosis
|
Portier, Irina
|
|
|
22 |
9 |
p. 2576-2588
|
artikel
|
| 3 |
Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH
|
Carlin, Stephanie
|
|
|
22 |
9 |
p. 2653-2669
|
artikel
|
| 4 |
Association between thrombus composition and first-pass recanalization after thrombectomy in acute ischemic stroke
|
Vandelanotte, Sarah
|
|
|
22 |
9 |
p. 2555-2561
|
artikel
|
| 5 |
Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort
|
de Kovel, Marloes S.
|
|
|
22 |
9 |
p. 2460-2469
|
artikel
|
| 6 |
Codon switching of conserved Ser residues in coagulation and fibrinolytic proteases
|
Stojanovski, Bosko M.
|
|
|
22 |
9 |
p. 2495-2501
|
artikel
|
| 7 |
Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data: comment from Berkowitz et al.
|
Berkowitz, Callie
|
|
|
22 |
9 |
p. 2674-2675
|
artikel
|
| 8 |
Concizumab improves clot formation in hemophilia A under flow
|
Jewell, Megan P.
|
|
|
22 |
9 |
p. 2438-2448
|
artikel
|
| 9 |
Cutting the Gordian knot of neutrophil extracellular traps research
|
Denorme, Frederik
|
|
|
22 |
9 |
p. 2419-2421
|
artikel
|
| 10 |
Evidence, what’s in a name? Some methodological remarks on the Grading of Recommendations Assessment, Development, and Evaluation approach for guideline development
|
Dekkers, Olaf M.
|
|
|
22 |
9 |
p. 2410-2412
|
artikel
|
| 11 |
Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19
|
Eustes, Alicia S.
|
|
|
22 |
9 |
p. 2514-2530
|
artikel
|
| 12 |
Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody
|
Frunt, Rowan
|
|
|
22 |
9 |
p. 2562-2575
|
artikel
|
| 13 |
Gelsolin regulates receptor-mediated and fluid-phase endocytosis in platelets
|
Paul, Manoj
|
|
|
22 |
9 |
p. 2601-2607
|
artikel
|
| 14 |
Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia
|
Betticher, Coralie
|
|
|
22 |
9 |
p. 2482-2494
|
artikel
|
| 15 |
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models
|
Becattini, Cecilia
|
|
|
22 |
9 |
p. 2502-2513
|
artikel
|
| 16 |
International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology
|
Rezende, Suely M.
|
|
|
22 |
9 |
p. 2629-2652
|
artikel
|
| 17 |
Issue Information
|
|
|
|
22 |
9 |
p. e1-e5
|
artikel
|
| 18 |
ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology: considerations for practice management and implementation
|
Ní Áinle, Fionnuala
|
|
|
22 |
9 |
p. 2404-2409
|
artikel
|
| 19 |
ISTH News and Updates: Join the ISTH Today
|
|
|
|
22 |
9 |
p. 2676
|
artikel
|
| 20 |
“2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19”: comment from Flumignan et al.
|
Flumignan, Ronald Luiz Gomes
|
|
|
22 |
9 |
p. 2670-2671
|
artikel
|
| 21 |
“2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19”: reply
|
Schulman, Sam
|
|
|
22 |
9 |
p. 2672-2673
|
artikel
|
| 22 |
Pathogenic but sweet: factor VIII inhibitor hits the hot spot
|
Kolyadko, Vladimir N.
|
|
|
22 |
9 |
p. 2416-2418
|
artikel
|
| 23 |
Plasma levels of complement components C5 and C9 are associated with thrombin generation
|
Vacik Díaz, Rocío
|
|
|
22 |
9 |
p. 2531-2542
|
artikel
|
| 24 |
Prediction of inhibitor development in previously untreated and minimally treated children with severe and moderately severe hemophilia A using a machine-learning network
|
Jardim, Letícia Lemos
|
|
|
22 |
9 |
p. 2426-2437
|
artikel
|
| 25 |
Pros and cons of the ISTH treatment guidelines for hemophilia
|
Mannucci, Pier Mannuccio
|
|
|
22 |
9 |
p. 2413-2415
|
artikel
|
| 26 |
Rapid high-throughput method for investigating physiological regulation of neutrophil extracellular trap formation
|
Zukas, Kieran
|
|
|
22 |
9 |
p. 2543-2554
|
artikel
|
| 27 |
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study
|
Guman, Noori A.M.
|
|
|
22 |
9 |
p. 2470-2481
|
artikel
|
| 28 |
Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain
|
Childers, Kenneth C.
|
|
|
22 |
9 |
p. 2449-2459
|
artikel
|
| 29 |
Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study
|
Dubut, Jade
|
|
|
22 |
9 |
p. 2589-2600
|
artikel
|
| 30 |
The enigma of factor XII surface binding
|
Silbak, Sadiq
|
|
|
22 |
9 |
p. 2422-2425
|
artikel
|
| 31 |
Thromboembolic and bleeding risk in cardiac amyloidosis
|
Tana, Marco
|
|
|
22 |
9 |
p. 2381-2392
|
artikel
|
| 32 |
Venous thromboembolic disease genetics: from variants to function
|
Underwood, Mary
|
|
|
22 |
9 |
p. 2393-2403
|
artikel
|
Tijdschrift beschrijving